End-of-day quote
Other stock markets
|
||
- USD | - |
06-03 | Transcript : CV Sciences, Inc. - Shareholder/Analyst Call | |
05-14 | CV Sciences Seeks M&A Opportunities | CI |
Sales 2022 | 16.2M 1.27B | Sales 2023 | 16M 1.25B | Capitalization | 5.47M 428M |
---|---|---|---|---|---|
Net income 2022 | -9M -704M | Net income 2023 | 3M 235M | EV / Sales 2022 | 0.36 x |
Net Debt 2022 | 917K 71.73M | Net cash position 2023 | 875K 68.45M | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-0.44
x | P/E ratio 2023 |
1.77
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
Latest transcript on CannaVEST Corp
Managers | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 15/06/14 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 25/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 15/06/14 |
Jamie Corroon
BRD | Director/Board Member | 54 | 20/07/22 |
William McCorkle
BRD | Director/Board Member | 56 | 20/10/22 |
1st Jan change | Capi. | |
---|---|---|
+43.21% | 749B | |
+39.42% | 605B | |
-6.66% | 351B | |
+18.75% | 328B | |
+8.09% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.23% | 167B | |
+5.69% | 165B |